Oliver Braubach
About Oliver Braubach
Oliver Braubach serves as the Director of Research & Development at Canopy Biosciences, where he focuses on advancements in spatial biology. He has a diverse background in both academia and the private sector, with extensive experience in immunohistochemistry, optical imaging techniques, and drug development.
Current Role at Canopy Biosciences
Oliver Braubach serves as the Director of Research & Development at Canopy Biosciences, a position he has held since 2023. In this role, he focuses on advancing research initiatives and developing innovative solutions in the field of spatial biology. His contributions are aimed at enhancing the understanding of biological systems through advanced imaging and analysis techniques.
Previous Experience at Akoya Biosciences
Prior to his current role, Oliver Braubach worked at Akoya Biosciences, Inc. in various capacities. He served as Senior Manager Applications from 2020 to 2022 and then as Director of Applications from 2022 to 2023. During his tenure, he was involved in the development and application of advanced imaging technologies, contributing to the company's growth in spatial biology.
Academic Background and Research Experience
Oliver Braubach has a strong academic foundation, having earned a Bachelor of Science (B.Sc.) in Neuroscience from Dalhousie University from 1999 to 2003. He furthered his education at the same institution, obtaining a Doctor of Philosophy (Ph.D.) in Physiology and Biophysics from 2004 to 2011. His postdoctoral research experience includes positions at the Korea Institute of Science and Technology and Yale University School of Medicine, where he focused on various aspects of biological research.
Expertise in Imaging and Assays
Oliver Braubach possesses expertise in several advanced techniques relevant to biological research. He is proficient in conducting biodistribution assays and skilled in optical imaging techniques, including in vivo and tissue imaging. His knowledge extends to high and superplex immunohistochemistry (IHC) and spatial transcriptomics, enabling him to contribute effectively to projects in the field.
Experience in Drug Development
Oliver Braubach has experience in biologics and small molecule drug development. His background includes roles that required a strong understanding of next-generation sequencing (NGS) and bioinformatic analyses, equipping him with the skills necessary to navigate complex research challenges in the pharmaceutical and biotechnology sectors.